相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
Geert J. Behets et al.
KIDNEY INTERNATIONAL (2015)
Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease
Domenico Russo et al.
JOURNAL OF NEPHROLOGY (2015)
Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
Julia B. Lewis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Abnormal Mineral Metabolism and Mortality in Hemodialysis Patients With Secondary Hyperparathyroidism: Evidence From Marginal Structural Models Used to Adjust for Time-Dependent Confounding
Masafumi Fukagawa et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Novel, Selective Vitamin D Analog Suppresses Parathyroid Hormone in Uremic Animals and Postmenopausal Women
Julia B. Zella et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Biomarkers of Vascular Calcification and Mortality in Patients with ESRD
Julia J. Scialla et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Use of Fibroblast Growth Factor 23 Testing in Patients with Kidney Disease
Edward R. Smith
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
Juergen Floege et al.
KIDNEY INTERNATIONAL (2014)
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients
Kevin J. Martin et al.
KIDNEY INTERNATIONAL (2014)
Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects
Kevin J. Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Sophie Liabeuf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Mario Cozzolino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Laboratory Abnormalities in CKD-MBD: Markers, Predictors, or Mediators of Disease?
Pieter Evenepoel et al.
SEMINARS IN NEPHROLOGY (2014)
Comparison of AMG 416 and cinacalcet in rodent models of uremia
Sarah Walter et al.
BMC NEPHROLOGY (2014)
Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial
Biagio Di Iorio et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Evaluating Real-World Use of Cinacalcet and Biochemical Response to Therapy in US Hemodialysis Patients
Ryan D. Kilpatrick et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?
Sharon M. Moe et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2013)
What can we learn from the US expanded end-stage renal disease bundle?
James D. Chambers et al.
HEALTH POLICY (2013)
The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial
Patrick S. Parfrey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression
Tilman B. Drueeke et al.
KIDNEY INTERNATIONAL (2013)
COSMOS: the dialysis scenario of CKD-MBD in Europe
Jose Luis Fernandez-Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era
Giovanni Conzo et al.
BMC SURGERY (2013)
Calcimimetics and outcomes in CKD
Tilman B. Drueeke
KIDNEY INTERNATIONAL SUPPLEMENTS (2013)
Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Sarah Walter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Observational Studies Versus Randomized Controlled Trials: Avenues to Causal Inference in Nephrology
Csaba P. Kovesdy et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2012)
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease
Hector Tamez et al.
AMERICAN HEART JOURNAL (2012)
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial
Ravi Thadhani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease
Pablo A. Urena Torres et al.
KIDNEY INTERNATIONAL (2012)
Vitamin D receptor activation and cardiovascular disease
Emilio Gonzalez-Parra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
Glenn M. Chertow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Role of Klotho in Aging, Phosphate Metabolism, and CKD
George B. John et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
John Cunningham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?
Mario Cozzolino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
Paolo Raggi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Does it Matter How Parathyroid Hormone Levels are Suppressed in Secondary Hyperparathyroidism?
Jason R. Stubbs et al.
SEMINARS IN DIALYSIS (2011)
Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
James B. Wetmore et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients
Yekaterina Gincherman et al.
HEMODIALYSIS INTERNATIONAL (2010)
Roles of Calcium-Sensing Receptor and Vitamin D Receptor in the Pathophysiology of Secondary Hyperparathyroidism
Linda M. McCann et al.
JOURNAL OF RENAL NUTRITION (2010)
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2010)
PERILS OF EVIDENCE-BASED MEDICINE
Ben A. Williams
PERSPECTIVES IN BIOLOGY AND MEDICINE (2010)
Physiology and pathophysiology of the calcium-sensing receptor in the kidney
Daniela Riccardi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Pathophysiology of Calcium and Phosphate Metabolism Impairment in Chronic Kidney Disease
Mario Cozzolino et al.
BLOOD PURIFICATION (2009)
Identification of calcium sensing receptor (CaSR) mRNA-expressing cells in normal and injured rat brain
Giuseppa Mudo et al.
BRAIN RESEARCH (2009)
Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period
Kishiko Nakajima et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Secondary Hyperparathyroidism: Pathophysiology and Treatment
Wissam Saliba et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2009)
Cinacalcet and achievement of the NKF/K-DOQI(TM) recommended target values for bone and mineral metabolism in real-world clinical practice-the ECHO observational study
Pablo Urena et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Alternatives to the randomized controlled trial
Stephen G. West et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2008)
Vitamin D deficiency and risk of cardiovascular disease
Thomas J. Wang et al.
CIRCULATION (2008)
Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment - Phase I, open-label, parallel-group, single-dose, single-centre study
Desmond Padhi et al.
CLINICAL DRUG INVESTIGATION (2008)
The OPTIMA study: Assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism
Piergiorgio Messa et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cinacalcet HCl and Concurrent Low-dose Vitamin D Improves Treatment of Secondary Hyperparathyroidism in Dialysis Patients Compared with Vitamin D Alone: The ACHIEVE Study Results
Steven Fishbane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics
William G. Goodman et al.
KIDNEY INTERNATIONAL (2008)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
W. N. Suki et al.
KIDNEY INTERNATIONAL (2007)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: A cost utility analysis
Rajeev Narayan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Drug Insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
Alex J. Brown et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
A. Levin et al.
KIDNEY INTERNATIONAL (2007)
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
J Cunningham et al.
KIDNEY INTERNATIONAL (2005)
Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study
P Evenepoel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Bone morphogenetic proteins in vascular calcification
KA Hruska et al.
CIRCULATION RESEARCH (2005)
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
EW Young et al.
KIDNEY INTERNATIONAL (2005)
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate
AJ Hutchison et al.
NEPHRON CLINICAL PRACTICE (2005)
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
GA Block et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product
SM Moe et al.
AMERICAN JOURNAL OF NEPHROLOGY (2003)
Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases
M Fukagawa et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Intermittent doxercalciferol (1α-hydroxyvitamin D2) therapy for secondary hyperparathyroidism
JM Frazao et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
